Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
By: Régine Marlin, Morgane Créoff, Sylvie Merle, Magalie Jean-Marie-Flore, Mickaelle Rose, Sarah Malsa, Xavier Promeyrat, François Martin, Georges Comlan, Nicolas Rabia, Taoufiq Taouil, Irfane Issoufaly, Patrick Escarmant, Vincent Vinh-Hung, Odile Béra

Department of Molecular Cancer Genetic, University Hospital of Martinique, Fort de France, France.
2019-10-14; doi: 10.1002/pros.23960
Abstract

Background

In Martinique, prostate cancer (Pca) incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. Despite the demonstration of a strong familial component, identification of the genetic basis for hereditary Pca is challenging. The HOXB13 germline variant G84E (rs138213197) was described in men of European descent with Pca risk.

Methods

To investigate the potential involvement of HOXB13 mutations in Martinique, we performed sequencing of the HOXB13 coding regions of 46 index cases with early-onset Pca (before the age of 51). Additional breast cancers and controls were performed. All cancer cases analyzed in this study have been observed in the context of genetic counseling.

Results

We identified a rare heterozygous germline variant c.853delT (p.Ter285Lysfs) rs77179853, reported only among patients of African ancestry with a minor allele frequency of 3.2%. This variant is a stop loss reported only among patients of African ancestry with a frequency of 0.2%.

Conclusion

In conclusion, we think that this study provides supplementary arguments that HOXB13 variants are involved in Pca.



© 2020 Wiley Periodicals, Inc.

PMID:32040869






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements